This article is more than 5 years old. Information may no longer be current.

Iluvien J-code J7313 now active

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The J-code J7313 assigned to Iluvien by the CMS is now active and available, Alimera Sciences announced in a press release.

The code was added to the Healthcare Common Procedure Coding System and is expected to ease the billing and reimbursement process for physicians and patients who receive Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg), the release said. Alimera confirmed that pricing has entered into Part B average sales price consistent with the J-code.

“The availability of the Iluvien J-code J7313 on January 1, 2016, will facilitate product reimbursement for physicians and we believe will improve treatment accessibility for patients suffering from diabetic macular edema,” Dan Myers, CEO of Alimera, said in the release.